Clinical Trial Update: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of selinexor with R-CHOP for high-risk germinal center B-cell subtype diffuse large B-cell lymphoma; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Selinexor (selinexor)
• Vincristine (vincristine)

Snippet

Sponsor: Li Zhiming | Conditions: DLBCL Germinal Center B-Cell Type | Phase 2 | Status: RECRUITING